{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:52:46Z","timestamp":1793940766635,"version":"4.8.0"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Periodontal Research"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Our aim was to estimate the prevalence of gingival overgrowth (hyperplasia) and to determine whether active molecules affect the severity of overgrowth in a group of epileptic patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>The effects of phenytoin on oral health have been explored in different studies, yet little information is available on other antiepileptic drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected from 213 subjects of both sexes, from 5 to 80\u00a0years. Patients taking the same antiepileptic therapy for at least 1\u00a0year and meeting the inclusion criteria of the study (n\u00a0=\u00a0162) were subjected to measurement of gingival overgrowth according to the modified Harris and Ewalt classification and O\u2019Leary's plaque control record (OLR). Descriptive statistics were calculated. Data were analyzed using Pearson's r correlation coefficient and chi\u2010square test. Significance level was set at 5%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The active drugs lamotrigine, oxcarbazepine, and phenobarbital were significantly associated with gingival overgrowth in 61%, 71%, and 53% of cases, respectively, and phenytoin, valproic acid, and carbamazepine in 50%, 44%, and 32% of cases, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Different antiepileptic molecules may be related to gingival overgrowth. In addition to phenytoin, also lamotrigine, oxcarbazepine, and phenobarbital were associated with increased prevalence of gingival overgrowth. In the management of epileptic patients, dentists should take into account different drugs as possible causes for gingival overgrowth and warn for possible alternatives.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jre.12828","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T18:02:35Z","timestamp":1608832955000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gingival overgrowth induced by anticonvulsant drugs: A cross\u2010sectional study on epileptic patients"],"prefix":"10.1111","volume":"56","author":[{"given":"Claudio","family":"Gallo","sequence":"first","affiliation":[{"name":"Department of Neuroscience University of Padova Padova Italy"},{"name":"\u2018Immacolata Concezione\u2019 Hospital Piove di Sacco Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Bonvento","sequence":"additional","affiliation":[{"name":"Department of Neuroscience University of Padova Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Zagotto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences University of Padova Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5307-0414","authenticated-orcid":false,"given":"Carla","family":"Mucignat\u2010Caretta","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine University of Padova Padova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090952"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2012.01878.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411910020010201"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1996.tb02072.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022034515571265"},{"key":"e_1_2_7_7_1","first-page":"1","article-title":"The effects of antiepileptic drugs on oral health","volume":"77","author":"Cornacchio ALP","year":"2011","journal-title":"J Can Dent Assoc"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0528.1992.tb01701.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1993.tb02118.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199510000-00002"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1998.tb02362.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-204670"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.4103\/0972-124X.113066"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874210601711010420"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2007.060165"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2006.00927.x"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0765.2003.00692.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2006.00930.x"},{"key":"e_1_2_7_19_1","first-page":"73","article-title":"Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation","volume":"20","author":"Prasad VN","year":"2002","journal-title":"J Indian Soc Pedod Prev Dent"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1972.43.1.38"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1992.63.6.548"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1994.65.7.666"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/275172"},{"issue":"89","key":"e_1_2_7_24_1","first-page":"1","article-title":"A new classification scheme for periodontal and peri\u2010implant diseases and conditions \u2010 introduction and key changes from the 1999 classification","volume":"2018","author":"Caton JG","year":"1999","journal-title":"J Clin Periodontol"},{"issue":"3","key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.17712\/nsj.2016.3.20150766","article-title":"Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan","volume":"21","author":"Murtaja A","year":"2016","journal-title":"Neurosciences"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1985.tb01377.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2009.02965.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-017-0088-5"},{"key":"e_1_2_7_29_1","first-page":"CD003615","article-title":"Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review (Review)","volume":"10","author":"Nevitt SJ","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874210601913010430"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.11138\/orl\/2017.10.3.221"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2144"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2018.10.002"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173582"}],"container-title":["Journal of Periodontal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jre.12828","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jre.12828","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jre.12828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T23:49:43Z","timestamp":1693698583000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jre.12828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/jre.12828"],"URL":"https:\/\/doi.org\/10.1111\/jre.12828","archive":["Portico"],"relation":{},"ISSN":["0022-3484","1600-0765"],"issn-type":[{"value":"0022-3484","type":"print"},{"value":"1600-0765","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"assertion":[{"value":"2020-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}